List of works by Silvio E Inzucchi

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

scientific article published on 21 March 2019

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

scientific article published on 6 June 2005

An internet service supporting quality assessment of inpatient glycemic control

scientific article

Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics

scientific article published on 21 March 2019

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?

scientific article published on 03 January 2020

Aspirin for primary prevention of cardiovascular events in people with diabetes, etc.

scientific article

Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR)

scientific article published on 09 August 2018

Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME

scientific article published on 06 February 2020

Association of inpatient and outpatient glucose management with inpatient mortality among patients with and without diabetes at a major academic medical center.

scientific article

Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study.

scientific article

BRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between?

scientific article

Bladder cancer in the EMPA-REG OUTCOME trial.

scientific article published on 14 September 2017

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

scientific article

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

scientific article published on 28 February 2017

Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial

scientific article

Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial

scientific article published on 02 June 2020

Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

scientific article published in January 2018

Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.

scientific article published on 13 November 2017

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

scientific article published on 26 August 2018

Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose co-transporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial

scientific article published on 09 November 2020

Chromium Picolinate for the Prevention of Type 2 Diabetes.

scientific article

Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus.

scientific article

Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience

scientific article

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association

scientific article published on 13 April 2020

Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry

scientific article published on 14 February 2019

Computing performance measures for inpatient glucose management.

scientific article published on January 2006

Consistent Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of Diabetic Kidney Disease Categories - Insights from the EMPA-REG OUTCOME trial

scientific article published on 03 August 2020

Counterpoint: Inpatient glucose management: a premature call to arms?

scientific article

Critical issues in endocrinology

scientific article published on December 2003

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

scientific article published on 16 September 2019

Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF

scientific article published on 16 July 2020

Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction

scholarly article

Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists ⬇️

journal article from 'JACC: Heart Failure' published in 2021

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

scientific article published on 19 September 2019

Decade-long trends in mortality among patients with and without diabetes mellitus at a major academic medical center

scientific article

Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial

scientific article published on 29 March 2018

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

scientific article published in August 2004

Dethroning the king?: The future of metformin as first line therapy in type 2 diabetes

scientific article published on 21 March 2019

Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy

scientific article published on 22 December 2006

Diabetes prevention and cardiovascular complications

scientific article published on 14 September 2019

Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error?

scientific article published on September 2012

Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes

scientific article published on 30 March 2010

EMPAGLIFLOZIN IS ASSOCIATED WITH A LOWER RISK OF POST-ACUTE HEART FAILURE RE-HOSPITALIZATION AND MORTALITY: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL

scholarly article

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial

scientific article published on 05 July 2020

Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF

scientific article published on 04 September 2020

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

scientific article published on 27 March 2020

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

scientific article published on 21 August 2020

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

scientific article published in The Lancet

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

scientific article published on 17 November 2019

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

scientific article published on 28 March 2020

Effects of dapagliflozin in heart failure with reduced ejection fraction, and COPD: An analysis of DAPA-HF

scientific article published on 23 December 2020

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial

scientific article published on 01 December 2020

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

scientific article published on 28 August 2017

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

scientific article

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

scientific article published on 22 September 2017

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

scientific article published on 17 November 2019

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial

scientific article published on 01 November 2019

Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF

scientific article published on 15 June 2020

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF

scientific article published on 12 October 2020

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial

scientific article published on 09 December 2019

Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?

scientific article published on 17 October 2013

Elevated admission glucose and mortality in elderly patients hospitalized with heart failure

scientific article published on 30 March 2009

Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality

scientific article published on 01 March 2019

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

scientific article published on 01 March 2019

Empagliflozin Reduces Mortality and Hospitalization for Heart Failure in Patients with Type 2 Diabetes and Peripheral Artery Disease: A Sub-Analysis of the EMPA-REG OUTCOME Trial

scholarly article

Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial

scientific article published on 13 November 2017

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

scientific article

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

scientific article published on 13 September 2017

Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial

scientific article published on 12 October 2018

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

scientific article published on 14 June 2016

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

scientific article published on 15 May 2020

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

scientific article

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

scientific article published on 19 May 2018

Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial

scientific article published on 29 March 2020

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article published on 01 March 2016

Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry

scientific article

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later

scientific article published on 12 March 2019

Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis. ⬇️

scientific article

Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study

scientific article published on 06 January 2012

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

scientific article published on 11 February 2008

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

scientific article published on 27 June 2019

Glucose normalization and outcomes in patients with acute myocardial infarction

scientific article

Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial

scientific article published on 26 July 2015

Glycemic management of diabetes in the perioperative setting

scientific article

HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study

scientific article published on 30 July 2013

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

scientific article published on 01 September 2018

Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes

scientific article published on 21 September 2016

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

scientific article

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 4 December 2017

How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial

scholarly article

How do we define cure of diabetes?

scientific article published on November 2009

How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?

scientific article

INTERINDIVIDUAL VARIABILITY IN WEIGHT LOSS WITH LORCASERIN: AN ANALYSIS FROM THE CAMELLIA-TIMI 61 STUDY

scholarly article

Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

scientific article

Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control

article

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes ⬇️

scientific article published on August 19, 2010

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

scientific article published in July 2005

Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

scientific article

Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease

scientific article published on 01 October 2018

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial

scientific article published on 01 January 2019

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

scientific article

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

scientific article (publication date: May 2002)

Metabolic rehabilitation: science gathers to support a new intervention to prevent stroke

scientific article published on 13 October 2011

Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease

scientific article published on 03 December 2018

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

scientific article published on 26 November 2020

Metformin and thiazolidinedione use in Medicare patients with heart failure

scientific article

Metformin in heart failure

scientific article published in December 2007

Metformin in patients with type 2 diabetes and kidney disease: a systematic review

scientific article published on December 2014

Metformin therapy in patients with type 2 diabetes complicated by heart failure

scientific article published on 25 October 2007

Metformin: new understandings, new uses

scientific article (publication date: 2003)

National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.

scientific article

New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications

scientific article published on January 2008

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

scientific article published on January 2008

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

scientific article published on 01 July 2017

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

scientific article

PERSISTENCE OF VALVULOPATHY IN THE CAMELLIA-TIMI 61 TRIAL OF LORCASERIN IN OBESE OR OVERWEIGHT PATIENTS AT INCREASED CARDIOVASCULAR RISK

scholarly article

Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action

scientific article published on July 2013

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?

scientific article published on 09 November 2020

Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR)

scientific article published on 18 June 2018

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

scientific article published on June 2013

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

scientific article published on 27 July 2016

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

scientific article published on 30 October 2017

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

scientific article published on 01 May 2019

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

scientific article published on 17 February 2016

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

scientific article

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

scientific article

Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke

scientific article published in May 2003

Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography

scientific article published on April 2010

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

scientific article published in January 2005

Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®.

scientific article published on 11 August 2017

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

scientific article

Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project

scientific article published in January 2017

Recognition of incident diabetes mellitus during an acute myocardial infarction

scientific article published on 21 April 2015

Redefining the diagnosis of diabetes using glycated hemoglobin

scientific article published in July 2009

Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction

scientific article published on 12 March 2012

Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial

scientific article published on 01 January 2020

Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction

scientific article published in April 2009

Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medications

scientific article published on 15 May 2020

Renoprotective effects of sodium-glucose cotransporter-2 inhibitors

scientific article published on 05 May 2018

Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study

scientific article (publication date: November 2007)

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

scientific article published in October 2017

Response by Zinman et al to Letter Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk".

scientific article

SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials

scientific article

SUN-149 Cardiologist vs. Endocrinologist Encounters in Patients with T2D and CVD: Potential Implications for Glucose-Lowering Therapy Use and Education.

scientific article

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

scientific article published on 10 December 2018

Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus

scientific article

Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 06 September 2020

Smoking cessation and outcome after ischemic stroke or TIA.

scientific article published on 8 September 2017

Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series

scientific article published on 31 May 2020

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

scientific article published on 16 November 2020

THE ASSOCIATION BETWEEN URIC ACID LEVELS AND CARDIORENAL OUTCOMES AND DEATH IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME

scholarly article

Taking care of volunteers in a stroke trial: a new assisted-management strategy

scientific article published on September 2016

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

scientific article

Temporal trends and hospital variation in the management of severe hyperglycemia among patients with acute myocardial infarction in the United States

scientific article published on 25 June 2013

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

scientific article

The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics

scientific article published on 15 July 2019

The authors reply

article published in 2020

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

scientific article

The prevention of type 2 diabetes mellitus.

scientific article

The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction

scientific article

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

scientific article published in February 2005

Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?

scientific article published on 01 May 2019

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.

scientific article

Type 2 diabetes therapy. A pathophysiologically based approach

scientific article

U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS

scientific article published in 2022

Understanding Contemporary Use of Thiazolidinediones

scientific article published on 01 June 2019

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

scientific article

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

scientific article

Use of metformin in the setting of mild-to-moderate renal insufficiency

scientific article

Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study

scientific article published on 10 July 2014

Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging

scientific article published on 01 May 2006

Paulina is supported by:

About Paulina

Help